Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk.

← Back to stories
National6 articles from 6 sources across the spectrum· Updated 326d ago

3 across the spectrum · tap a section to jump

How each side is putting it

Left

0 viewpoints

No Left coverage yet.

A blind spot on this side of the story.

Center

1 viewpoint
Ran by 4 outlets· WFMZ Allentown, WDIO Duluth, +2 more
WFMZ AllentownCenter· 326d ago

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

WDIO DuluthCenter· 326d ago

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

KOB 4Center· 326d ago

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

NBC New YorkLean Left· 326d ago

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

Right

2 viewpoints
FOX BusinessLean Right· 326d ago

Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition

New York PostLean Right· 326d ago

Pfizer wins $10 billion bidding war for obesity drug developer

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk | Slantwise